VeriMomDois-je éviter ci 77947 pendant la grossesse ? | VeriMom
Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
ECHA regulatory hazard statements
- •H400
- •H410
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ci 77947 est-il sûr pendant la grossesse ?
- Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
- ci 77947 est-il sûr pendant l'allaitement ?
- Because dermal/systemic absorption of zinc oxide from topical formulations is negligible under normal use (per SCCS/CIR assessments), maternal systemic exposure that could transfer to breast milk is not expected. No authoritative evidence of reproductive/lactational toxicity from harmonised classifications.
- ci 77947 est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no infant-specific reproductive/toxic mechanism identified. Exposure: while adult dermal absorption is negligible, zinc oxide is not absolutely non-absorbable and infants (0–3 yr) have an immature skin barrier/higher surface‑area‑to‑body‑weight, so exposure score is increased by +1 relative to adults. SCCS/CIR accept topical use (including in sunscreens and barrier creams) given minimal systemic uptake, but infant-specific absorption data are limited.
- Comment VeriMom évalue-t-il ci 77947 ?
- VeriMom évalue ci 77947 à 39/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ci 77947 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ci 77947 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.